000 | 01222cam a2200337 a 4500 | ||
---|---|---|---|
001 | 091239 | ||
003 | OCoLC | ||
005 | 20210921174928.0 | ||
008 | 030923s2004 njua b 001 0 eng c | ||
020 | _a0471601500 (cloth) | ||
020 |
_a9780471601500: _c£38.95 |
||
040 |
_aPUL _cPUL _dNLM _dTKN _dOCL _dBAKER _dNLGGC |
||
042 | _apcc | ||
082 |
_a615.19 _bNG |
||
100 | 1 |
_aNg, Rick. _941189 |
|
245 | 1 | 0 |
_aDrugs : _bfrom discovery to approval / |
260 |
_aHoboken, N.J. : _bWiley-Liss, _c2004. |
||
300 |
_axii, 355 p. : _bill. ; _c24 cm. |
||
336 |
_atext _2rdacontent |
||
337 |
_aunmediated _2rdamedia |
||
338 |
_avolume _2rdacarrier |
||
504 | _aIncludes bibliographical references and index. | ||
520 | 8 | _aThis volume offers a step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of pre-clinical studies, the conduct of human clinical trials, regulatory controls and manufacturing of drugs. | |
650 |
_aPharmaceutics _xResearch |
||
650 | 0 |
_aDrug development. _932738 |
|
902 | _a170509 | ||
907 |
_a.b10477688 _bsmmai _c- |
||
942 | _n0 | ||
948 | _hNO HOLDINGS IN LQI - 279 OTHER HOLDINGS | ||
998 |
_b0 _c060726 _dm _ea _g0 |
||
999 |
_c45034 _d45034 |